← Back to Clinical Trials
Recruiting NCT06781840

NCT06781840 Promoting Health Through Play Program: Improving Parent and Child Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06781840
Status Recruiting
Phase
Sponsor Yeshiva University
Condition Child Development
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2022-01-21
Primary Completion 2025-12-05

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 5 Years
Study Type INTERVENTIONAL
Interventions
Playing Playfully to Overcome Adversity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2022-01-21 with a primary completion date of 2025-12-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project aims to assess the feasibility of an intervention program consisting of parent online group sessions in addition to guided individual play session between parent, child, and occupational therapy student (OTS) or an occupational therapist (OT). The investigators speculate that the Promoting Health Through Play Opportunities program will be effective in improving: 1. Parent ability to support their child's playfulness as measured during 15-minute video-recorded joint play activity at home using the Parent/Caregiver Support of Childre Playfulness \[PC-SCP\]. 2. Child's playfulness behavior as measured during 15-minute video-recorded joint play activity at home using the Test of Playfulness \[ToP\]. 3. Child's psychological adjustment as measured by the Strength and Difficulties Questionnaire \[SDQ\]. 4. Parent's perception and satisfaction from their involvement in the program as measured through open-ended questions.

Eligibility Criteria

Inclusion Criteria: * Enrolled in Head Start pre-school program within New York greater area * Parent-child dyads * Child must be 3 to 5 years old, with/without delay or disability. * If a parent has more than one child in this age range, the oldest of them will be recruited for the study * Parent IS committed to attending pre-and-posttest as well as online group sessions * Parent has access to a device other than a phone (tablet, iPad, laptop) and has stable internet connection to be able to participate in the online group and dyadic session * For the English-speaking group, parent must be fluent in English * For the Spanish speaking group, parent must be fluent in the Spanish language. Exclusion Criteria: * Parents with a sensory deficit (e.g., hearing or vision impairment) that will affect their ability to participate in an online group program * Parents with psychiatric or behavioral disorders that affect their ability to participate in a group-based intervention

Contact & Investigator

Central Contact

Clinical Professor, Director of Scholarship and Research

✉ amiya.waldmanlevi@yu.edu

📞 646.592.4765

Frequently Asked Questions

Who can join the NCT06781840 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 5 Years, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06781840 currently recruiting?

Yes, NCT06781840 is actively recruiting participants. Contact the research team at amiya.waldmanlevi@yu.edu for enrollment information.

Where is the NCT06781840 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT06781840 clinical trial?

NCT06781840 is sponsored by Yeshiva University. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology